BiVACOR’s artificial heart uses magnetic levitation and one moving part to rethink how blood is pumped.
Photo source:
BiVACOR
Heart failure is
one of the most serious health problems in the world. For some people, medicine
and surgery aren’t enough, and a heart transplant becomes the only option. But
donor hearts are limited. That’s where BiVACOR comes in. The company is working
on a Total Artificial Heart (TAH), a device meant to fully replace the function
of a human heart.
What makes the
BiVACOR TAH different is how it works. At its center is one moving part, a
small spinning disc called a rotor. This rotor floats in place using magnetic
forces and pushes blood to both the lungs and the rest of the body. Because the
rotor doesn’t touch anything, there’s less wear and tear, and it can keep
working over time.
The device is made
of strong, lightweight titanium and is small enough to fit most adult patients.
It’s powered by an external controller and battery pack that patients wear,
giving them the ability to move around while still being connected to the device.
This setup helps people stay more active, even while waiting for a heart
transplant.
BiVACOR is now
testing its artificial heart in a U.S.-based Early Feasibility Study, approved
by the FDA. This study is focused on safety and how well the device works for
patients who are waiting for a donor heart. The results will help shape the
next steps toward making the device more widely available.
Please subscribe to have unlimited access to our innovations.